Steakholder Foods Ltd. · NASDAQ:STKH
Steakholder Foods — MeaTech 3D — Investor Presentation (May 2022)
28 slides from Steakholder Foods's investor presentation, May 11, 2022
Slide 1: Pioneering Meat 2.0 Investor Presentation May 2022
PIONEERING MEAT 2 . 0 TM TM Investor Presentation May 2022
Slide 2: Forward-looking statements
This presentation and oral statements made regarding the subject of this presentation contain “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. Such statements include, without limitation, re
Slide 3: Our Leadership Team
Our Leadership Team ARIK KAUFMAN Co-Founder & CEO Arik Kaufman has founded various Nasdaq and TASE traded food-tech firms. He is a founding partner of the BlueSoundWaves collective led by Ashton Kutcher, Guy Oseary and Effie Epstein. Mr. Kaufman has extensive experience in food-tech and biotech law,
Slide 4: MeaTech Highlights
MeaTech Highlights 2019 Initiated activities May 2022: $55M RAISED, +65 EMPLOYEES, 8 PATENT APPLICATIONS TO DATE 2022 Reported promising results with muscle stem cell differentiation into muscle fibers that better resemble whole cuts of meat Expanded into the US Commenced pilot plant in Belgium Held
Slide 5: Alternative Protein Market Overview
Alternative Protein Market Overview
Slide 6: Huge Market Potential
HUGE MARKET POTENTIAL GLOBAL DEMAND FOR PROTEINS IS DRIVING THE INDUSTRY… Sources: UN Food and Agriculture Organization (FAQ). AT Kearney Research. P L ANT BASED C ON V ENTIONAL MEAT C U LT URED MEAT In billions $US +3% 1,2001 1,400 1,600 1,800 2025 2030 2035 2040 90% 10% 18% 10% 22% 23% 35% 25% 72%
Slide 7: Evolving Alt-Meat Landscape
COMPLEXITY ORGANOLEPTIC PROPERTIES Plant-based alternative meat Cultivated hybrid meat1 TODA Y NASCENT Cultivated whole-cut premium meat BLEEDING EDGE EVOLVING ALT-MEAT LANDSCAPE Thin tissue of premium cultivated meat Note: 1 Up to 50% of cultivated meat ingredients.
Slide 8: First stop: The Best of Both Worlds - Hybrid Meats
First stop: The Best of Both Worlds CULTURED and PLANT-BASED: HYBRID MEATS
Slide 9: MeaTech's GTM Starting with Hybrid Products
MEATECH’S GTM STARTING WITH HYBRID PRODUCTS Completed the 1st acquisition of a company in the cultivated meat sector buying Belgium-based ‘Peace of Meat’ in Q1 2021 Focusing on improving the taste, texture and nutritional value of plant-based and cell-based proteins. Adding 10-25% of cultured fat or
Slide 10: MeaTech's Printing Real Meat
MeaTech’ PRINTING REAL MEAT
Slide 11: Meat 2.0 Potential Advantages for the Meat Industry
SUSTAINABILITY Cleaner, more recyclable inputs and lower emissions, and positive ESG impact SUPPLY CHAIN Shortened and simplified with production possible anywhere 2 . 0 PRODUCTS New ingredients and product categories, including potentially healthier products Note: The above illustration depicts our
Slide 12: Our commitment to the UN Sustainable Development Goals
Our commitment to the UNITED NATIONS 17 Sustainable Development Goals As part of MeaTech’s long-term sustainability strategy, we are in the process of collecting internal data in terms of water use, carbon footprint, and land use, in order to quantify and measure our impact in accordance with the UN
Slide 13: MeaTech Strategy & Business Model
Meatech Strategy & Business Model
Slide 14: Vision: Top 5 Global Cultured Meat Player by 2025
Notes: 1McKinsey, June 16, 2021: https://www.mckinsey.com/industries/agriculture/our-insights/cultivated-meat-out-of-the-lab-into-the-frying-pan. Medium growth scenario. MEATECH Vision: Top 5 GLOBAL CULTURED MEAT PLAYER BY 2025 CULTURED MEAT MARKET SIZING (Tons) 2025E Cultured meat market - end prod
Slide 15: Scale-up Roadmap 2022-2025
2022-2023 Belgium pilot plant with 2,000-liter capacity SCALE UP Technology REGULATION 2024-25 10K-liter bioreactor technology PRODUCTION CAPABILITIES 2024 US plant 10K-liter capacity +EU plant 10K-liter capacity 2025 2 new plants 10K-liter capacity each in the EU and in Asia 2022 200-liter bioreact
Slide 16: Pilot Plant and Global Plant Expansion
ANTWERP, BELGIUM 2,000 LITER PILOT PLANT Completion by 2Q-23 Expected CAPEX: EUR 15M Annual Yield: 23 tons biomass 2025 Target: Ramping up our production capabilities and expanding globally OVER 560 TONS OF BIOMASS PER ANNUMC. 17% SHARE OF THE PROJECTED GLOBAL ADDRESSABLE MARKET ANTWERP, BELGIUM 10,
Slide 17: 2025 Target: Financials
2025 Target: Financials Five production facilities globally, with total of 42,000 liters of bio-reactors at total capital expenditure of $120m Producing over 560 tons per annum of bio-mass, translating into 4,000 tons of end product(1) At manufacturer price of $25 per kg. of end product = $100m reve
Slide 18: Go To Market model
Go To Market model Cultivated meat biomass B2B Final product elaboration Structured cultivated meat products Unstructured cultivated meat products Producing cells at scale to make fat and protein biomass for use in end products Selling MeaTech’s ingredients as B2B products Using some proportion of c
Slide 19: Competitive Landscape
Company Valuation (USD) Total Funding (USD) 3D Printing Non-GMO Cell Lines Structured meat Ground Products Chicken Beef Pork Fish MeaTech 3D Ltd. Public 55 M(1) 55 M Eat Just- Good Meat 1B 170 M Upside Food 1B 606 M Mosa Meat 300-500M 168 M Blue Nalu 300-500M 84.8 M Future Meat Technologies 900M 387
Slide 20: Technology Overview
Technology Overview
Slide 21: MeaTech's Core R&D
HIGH THROUGHPUT 3D TISSUE ENGINEERING 3D PRINTING AND INCUBATION Scaffold materials Bio-ink formulations Software development Note: These images are computer generated and represent future expectations. MEATECH’S CORE R&D MULTI-SPECIES CELL-BASED MANUFACTURING WITH BIOREACTOR SYSTEMS & PROCESSES Tec
Slide 22: MeaTech's Cell-Based Process Vision
CELL COLLECTION CELL GROWTH Upon reaching sufficient cell quantities, stem cells are differentiated into fat and muscle cells. GROUND PRODUCTS Cell lines are developed to reliably express certain characteristics. Stem cells are transferred to bioreactors for exponential growth under ideal conditions
Slide 23: MeaTech's Cultured Steak Vision
MEATECH'S CULTURED STEAK VISION A FLEXIBLE MANUFACTURING PROCESS FOR 3D-PRINTED TISSUE BIO-INKS 3D BIOPRINTING INCUBATION STRUCTURED MEAT Bio-inks formulated from our cell lines and unique scaffolding materials are loaded into our 3D bioprinter. Bio-inks are accurately printed to assemble cells as t
Slide 24: MeaTech's IP
MEATECH’S IP 8 PATENT APPLICATIONS SUBMITTED - NOT YET GRANTED Cultivated Edible Meat Fabrication Using Bioprinting © 2021 ALL RIGHTS RESERVED Harvesting Bovine Embryonic Inner Cell Mass Physical Manipulation of Cultivated Tissue Bioprinter Printhead Design Growth Support For Cell Culture Bovine Umb
Slide 25: Thank You
THANK YOU! WWW.MEATECH3D.COM No Animals Were Harmed in the Making of This Slide deck
Slide 26: Appendices
Appendices
Slide 27: Appendix - Balance Sheet
Appendix - Balance Sheet ($, millions) 31-12-2021 31-12-2020 Current Assets 22.1 13.8 Non Current Assets 18.5 3.6 Total Assets 40.7 17.5 Current Liabilities 2.8 1.8 Non Current Liabilities 0.2 - Total Liabilities 3.0 1.8 Equity 37.6 15.6 Total Liabilities And Equity 40.7 17.5 SOLID BALANCE SHEET, WI
Slide 28: Regulatory Progress of Cultured Meat
Sources: Congressional Research Service; Regulation (EU); Food Navigator Asia; Singapore Food Agency. SINGAPORE Already approved cultured meat for sale in restaurants CHINA Positive announcements USA Formal agreement between the USDA and FDA EU Requires ‘novel food’ and food safety applications REGU